Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1138
Histopathology testing equipment market is envisioned to value over CAGR of over 4% from 2022 to 2028. Histopathology is the examination of diseases related to tissues. With the help of a microscope, the examination of tissues is done. It spots the characteristics of the disease. Histopathology testing equipment is widely utilized in medical laboratories for biological examinations. The rising cases of cancer and increasing prevalence of other chronic diseases are boosting the growth of the market. Higher demand for advanced histopathology alongside rising cases of melanoma has accelerated the growth of the market. The demand for histopathological testing equipment has created new space for manufacturers. The market is bifurcated on the basis of product type, by application, by the end user, and by region. The product is further divided into instruments and consumables. Instruments consist of tissue processor equipment, tissue embedding equipment, cover slipper systems, microscopes, microtome & cryostat, and others. The consumables segments consist of reagents & antibodies, probes, kits, others. The rising demands for reagents and antibodies are fueling the growth of the market. Kits and reagents are predicted to contribute to the growth of the market during the forecast. Rising demand for anatomic pathology services owing to huge usage of kits has accelerated the growth of the market. Kits are required in high number for sequencing and diagnosing of chronic diseases. The application is segmented into drug discovery, disease diagnosis, research application. Disease diagnosis is contributing to the histopathology testing equipment. Research application is also witnessed to dominate the growth of the market in the coming years. In terms of end user, the market is segmented into hospital-based laboratories, diagnostic centres, and research organizations. Hospital-based laboratories are expected to control the growth of the market during the forecast period. In terms of region, North America has emerged as the largest market. Presence of prominent alongside and developed healthcare infrastructure has fueled the growth of the market in the region. Asia-Pacific region is forecasted to achieve the highest growth. The rapid development of healthcare infrastructure alongside technological advancements has inflated the size of the market in the region. Key players of the market are Thermo Fisher Scientific, Advanced Cell Diagnostics Inc, Abbott Laboratories, Abcam, Omnyx, Monogram Biosciences, Sakura Fintek, and others. Histopathology Testing Equipment Market Segmentation By Product Type Instruments Tissue Processor Equipment Automatic Manual Tissue Embedding Equipment Slide Strainers Systems High-throughput Strainers Compact Strainers Cover slipper Systems Fully automated cover slipping workstation Flexible cover slipping workstation Microtome & Cryostat Rotatory/Manual Microtome Semi-Automatic Microtome Fully Automatic Microtome Manual Cryostat Fully Automatic Cryostat Semi-Automatic Cryostat Microscopes Other Instruments Consumables Reagents & antibodies Probes Kits Other consumables By Application Drug Discovery Disease Diagnosis Research Application By End Users Hospital-based laboratories Diagnostic Centers Research Organizations By Region Europe North America APAC Latin America Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key data points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the histopathology testing equipment market based on the product type, by application, by end users, and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization services offered are free of charge with purchase of any license of the report. You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Histopathology is the examination of diseases related to tissues. With the help of a microscope, the examination of tissues is done. It spots the characteristics of the disease. Histopathology testing equipment is widely utilized in medical laboratories for biological examinations. The rising cases of cancer and increasing prevalence of other chronic diseases are boosting the growth of the market.
Higher demand for advanced histopathology alongside rising cases of melanoma has accelerated the growth of the market. The demand for histopathological testing equipment has created new space for manufacturers.
The market is bifurcated on the basis of product type, by application, by the end user, and by region. The product is further divided into instruments and consumables. Instruments consist of tissue processor equipment, tissue embedding equipment, cover slipper systems, microscopes, microtome & cryostat, and others. The consumables segments consist of reagents & antibodies, probes, kits, others. The rising demands for reagents and antibodies are fueling the growth of the market. Kits and reagents are predicted to contribute to the growth of the market during the forecast. Rising demand for anatomic pathology services owing to huge usage of kits has accelerated the growth of the market. Kits are required in high number for sequencing and diagnosing of chronic diseases.
The application is segmented into drug discovery, disease diagnosis, research application. Disease diagnosis is contributing to the histopathology testing equipment. Research application is also witnessed to dominate the growth of the market in the coming years. In terms of end user, the market is segmented into hospital-based laboratories, diagnostic centres, and research organizations. Hospital-based laboratories are expected to control the growth of the market during the forecast period.
In terms of region, North America has emerged as the largest market. Presence of prominent alongside and developed healthcare infrastructure has fueled the growth of the market in the region. Asia-Pacific region is forecasted to achieve the highest growth. The rapid development of healthcare infrastructure alongside technological advancements has inflated the size of the market in the region.
Key players of the market are Thermo Fisher Scientific, Advanced Cell Diagnostics Inc, Abbott Laboratories, Abcam, Omnyx, Monogram Biosciences, Sakura Fintek, and others.
Histopathology Testing Equipment Market Segmentation By Product Type
By Application
By End Users
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Histopathology Testing Equipment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Histopathology Testing Equipment Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Histopathology Testing Equipment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Histopathology Testing Equipment Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Instruments 7.1.1. Tissue Processor Equipment 7.1.1.1. Automatic 7.1.1.2. Manual 7.1.2. Tissue Embedding Equipment 7.1.3. Slide Strainers Systems 7.1.3.1. High-throughput Strainers 7.1.3.2. Compact Strainers 7.1.4. Cover slipper Systems 7.1.5. Fully automated cover slipping workstation 7.1.6. Flexible cover slipping workstation 7.1.7. Microtome & Cryostat 7.1.7.1. Rotatory/Manual Microtome 7.1.7.2. Semi-Automatic Microtome 7.1.7.3. Fully Automatic Microtome 7.1.7.4. Manual Cryostat 7.1.7.5. Fully Automatic Cryostat 7.1.7.6. Semi-Automatic Cryostat 7.1.8. Microscopes 7.1.9. Other Instruments 7.2. Consumables 7.2.1. Reagents & antibodies 7.2.2. Probes 7.2.3. Kits 7.2.4. Other consumables 8. Histopathology Testing Equipment Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Drug Discovery 8.2. Disease Diagnosis 8.3. Research Application 9. Histopathology Testing Equipment Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital-based laboratories 9.2. Diagnostic Centers 9.3. Research Organizations 10. North America Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Thermo Fisher Scientific 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Advanced Cell Diagnostics Inc 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Abbott Laboratories 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Abcam 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Omnyx 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Qingdao Tian Hua Yi He Foundry Factory 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Monogram Biosciences 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Sakura Fintek 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Histopathology Testing Equipment Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Histopathology Testing Equipment Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Histopathology Testing Equipment Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Histopathology Testing Equipment Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Instruments 7.1.1. Tissue Processor Equipment 7.1.1.1. Automatic 7.1.1.2. Manual 7.1.2. Tissue Embedding Equipment 7.1.3. Slide Strainers Systems 7.1.3.1. High-throughput Strainers 7.1.3.2. Compact Strainers 7.1.4. Cover slipper Systems 7.1.5. Fully automated cover slipping workstation 7.1.6. Flexible cover slipping workstation 7.1.7. Microtome & Cryostat 7.1.7.1. Rotatory/Manual Microtome 7.1.7.2. Semi-Automatic Microtome 7.1.7.3. Fully Automatic Microtome 7.1.7.4. Manual Cryostat 7.1.7.5. Fully Automatic Cryostat 7.1.7.6. Semi-Automatic Cryostat 7.1.8. Microscopes 7.1.9. Other Instruments 7.2. Consumables 7.2.1. Reagents & antibodies 7.2.2. Probes 7.2.3. Kits 7.2.4. Other consumables
8. Histopathology Testing Equipment Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Drug Discovery 8.2. Disease Diagnosis 8.3. Research Application
9. Histopathology Testing Equipment Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital-based laboratories 9.2. Diagnostic Centers 9.3. Research Organizations
10. North America Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Histopathology Testing Equipment Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Thermo Fisher Scientific 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Advanced Cell Diagnostics Inc 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Abbott Laboratories 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Abcam 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Omnyx 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Qingdao Tian Hua Yi He Foundry Factory 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Monogram Biosciences 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Sakura Fintek 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics